AAPS PharmSci

, Volume 6, Issue 2, pp 7–16

Acute and subchronic (28-day) oral toxicity study in rats fed with novel surfactants

Article

Abstract

The toxicity of 2 new synthetic lipids, 1,2-dioleoyl-rac-glycerol-3-dodecaethylene glycol, GDO-12 (lipid 1) and 1,2-distearoyl-rac-glycerol-3-dodecaethylene glycol, GDS-12 (lipid 2) has been evaluated in acute and subchronic toxicity studies. Acute oral toxicity studies in male and female rats documented no deaths or treatment-related signs at high doses. The lipids were individually administered (by gavage) to male and female Sprague-Dawley rats at concentrations of 250, 500, and 1000 mg/Kg bodyweight for 28 days. All animals survived the duration of the study, with no significant changes in clinical signs, hematological parameters, organ weights, ophthalmology evaluations, or histopathological findings. These studies establish that both GDO-12 (lipid 1) and GDS-12 (lipid 2) are nontoxic in rats following oral administration. The no-observed-adverse-effect level ranged between 250 mg/Kg and 1000 mg/Kg following oral administration.

KeyWords

oral toxicity rats polyoxyethylene glycol (PEG) liposomes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lasic DD. Liposomes: From Physics to Applications. Oxford, UK: Elsevier Science Ltd; 1993.Google Scholar
  2. 2.
    Hunt CA. Liposomes disposition in vivo. Liposome stability in plasma and implications for drug carrier function. Biochim Biophys Acta. 1982;719(3):450–463.CrossRefPubMedGoogle Scholar
  3. 3.
    Oku N, Doi K, Namba Y, Okada, S. Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on meth-a-sarcoma-bearing mice. Int J Cancer. 1994;58:415–419.CrossRefPubMedGoogle Scholar
  4. 4.
    Gabizon A. Liposome circulation time and tumor targeting: implications for cancer chemotherapy. Adv Drug Deliv Rev. 1995;16:285–294.CrossRefGoogle Scholar
  5. 5.
    Gabizon A, Catane R, Uziely B, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994;54:987–992.PubMedGoogle Scholar
  6. 6.
    Adlakha-Hutcheon G, Bally MB, Shew CR, Madden TD. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol. 1999;17:775–779.CrossRefPubMedGoogle Scholar
  7. 7.
    Koning GA, Morselt HW, Velinova MJ, et al. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochim Biophys Acta. 1999;1420(1–2):153–167.CrossRefPubMedGoogle Scholar
  8. 8.
    Food and Agriculture Organization (FAO). Principles for the Safety Assessment of Food Additives and Contaminant in Food International Programme on Chemical Safety (IPCS) in co-operation with the project FAO/WHO expert committee on food additives (JECFA). Rome, Italy: Food and Agriculture Organization; 1987. Environmental Health Criteria 70.Google Scholar
  9. 9.
    Dacie VJ, Lewis SM. Practical Haematology. International student ed. Oxford, UK: Churchill Livingstone; 1984.Google Scholar
  10. 10.
    Brij MM, Rawnsley HM. Clinical, Biochemical and Hematological Reference Values in Normal Experimental Animals. Masson: New York; 1977.Google Scholar
  11. 11.
    Harris JM, Zalipsky S. Poly(ethylene glycol) Chemistry and Biological Applications. Washington, DC: ACS Publications; 1997.CrossRefGoogle Scholar
  12. 12.
    Lasic DD, Martin FJ. Stealth Liposomes. Boca Raton: CRC Press; 1995.Google Scholar
  13. 13.
    Keller BC, Lasic DD. Self-forming, thermodynamically stable liposomes and their applications. US patent 6 610 322, August 26, 2003.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2004

Authors and Affiliations

  1. 1.Indian Institute of ToxicologyPuneIndia
  2. 2.BioZone Laboratories IncPittsburg

Personalised recommendations